On-Demand Webcast

Share

Program Content

Activities

  • HER2-Positive Advanced GI Cancers
    HER2-Positive Advanced Gastrointestinal Cancers: Expert Guidance on Leveraging Targeted Agents to Improve Outcomes
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 21, 2023

    Expires: June 20, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Seagen Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Seagen Inc.